Preclinical evaluation of therapeutic vaccines for chronic hepatitis B that stimulate antiviral activities of T cells and NKT cells.

Saved in:
Bibliographic Details
Title: Preclinical evaluation of therapeutic vaccines for chronic hepatitis B that stimulate antiviral activities of T cells and NKT cells.
Authors: Mooney AH; Malaghan Institute of Medical Research, Wellington, New Zealand., Draper SL; Ferrier Research Institute, Victoria University of Wellington, Wellington, New Zealand., Burn OK; Malaghan Institute of Medical Research, Wellington, New Zealand., Anderson RJ; Ferrier Research Institute, Victoria University of Wellington, Wellington, New Zealand., Compton BJ; Ferrier Research Institute, Victoria University of Wellington, Wellington, New Zealand., Tang C; Malaghan Institute of Medical Research, Wellington, New Zealand., Farrand KJ; Malaghan Institute of Medical Research, Wellington, New Zealand., Di Lucia P; Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Ravà M; Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Fumagalli V; Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Giustini L; Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Bono E; Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Godfrey DI; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Victoria, Australia.; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Parkville, Australia., Heath WR; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Victoria, Australia., Yuan W; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Chisari FV; Department of Immunology & Microbial Sciences, The Scripps Research Institute, La Jolla, CA, USA., Guidotti LG; Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Iannacone M; Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Sidney J; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA., Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA., Gulab SA; Ferrier Research Institute, Victoria University of Wellington, Wellington, New Zealand.; Avalia Immunotherapies Limited, Wellington, New Zealand., Painter GF; Ferrier Research Institute, Victoria University of Wellington, Wellington, New Zealand., Hermans IF; Malaghan Institute of Medical Research, Wellington, New Zealand.
Source: JHEP reports : innovation in hepatology [JHEP Rep] 2024 Feb 12; Vol. 6 (5), pp. 101038. Date of Electronic Publication: 2024 Feb 12 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101761237 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5559 (Electronic) Linking ISSN: 25895559 NLM ISO Abbreviation: JHEP Rep Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-5559
DOI:10.1016/j.jhepr.2024.101038